Point72 Asset Management, L.P. - 04 Aug 2025 SCHEDULE 13G Report for Avalo Therapeutics, Inc. Common Stock, par value $0.001 per share (AVTX)

Filing Manager
Point72 Asset Management, L.P.
Reporting Manager
Point72 Asset Management, L.P.
Security
Avalo Therapeutics, Inc. Common Stock, par value $0.001 per share
Symbol
AVTX
Shares outstanding
10,900,593 shares
Disclosed Ownership
588,632 shares
Ownership
5.4%
Form type
SCHEDULE 13G
Filing time
05 Aug 2025, 16:58:33 UTC
Date of event
04 Aug 2025
Next filing
14 Nov 2025
SEC
View on sec.gov

Reporting Managers (3)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Point72 Asset Management, L.P. 5.4% 588,632 0 588,632 /s/ Jason M. Colombo Jason M. Colombo, Authorized Person
Point72 Capital Advisors, Inc. 5.4% 588,632 0 588,632 /s/ Jason M. Colombo Jason M. Colombo, Authorized Person
Steven A. Cohen 5.4% 588,632 0 588,632 /s/ Jason M. Colombo Jason M. Colombo, Authorized Person